Skip to main content
MelaNostrum Consortium – Selected Publications
- Stefanaki I, Stratigos AJ, Kypreou KP, et al. MC1R variants in relation to naevi in melanoma cases and controls: A pooled analysis from the M-SKIP project. J Eur Acad Dermatol Venereol 2021.
- Sargen MR, Calista D, Elder DE, et al. Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain. J Am Acad Dermatol 2020.
- Zhang YD, Hurson AN, Zhang H, et al. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nat Commun 2020.
- Caini S, Gandini S, Botta F, et al. MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: A pooled analysis from the M-SKIP project. Melanoma Res 2020.
- Landi MT, Bishop DT, MacGregor S, et al. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. Nat Gent 2020.
- Schlafly A, Pfeiffer RM, Nagore E, et al. Contribution of common genetic variants to familial aggregation of disease and implications for sequencing studies. PLoS Genet 2019.
- Taylor NJ, Mitra N, Qian L, et al. Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT. J Am Acad Dermatol 2019.
- Potrony M, Puig-Butille JA, et al. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families. Br J Dermatol 2019.
- Pellegrini C, Botta F, Massi D, et al. MC1R variants in childhood and adolescent melanoma: A retrospective pooled analysis of a multicentre cohort. Lancet Child Adolesc Health 2019.
- Stratigos AJ, Fargnoli MC, De Nicolo A, et al. MelaNostrum: A consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the MelaNostrum Consortium. J Eur Acad Dermatol Venereol 2018.
- Gu F, Chen TH, Pfeiffer RM, et al. Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma. Hum Mol Genet 2018.
- Tagliabue E, Gandini S, Bellocco R, et al. MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: A pooled analysis from the M-SKIP project. Cancer Manag Res 2018.
- Nagore E, Heidenreich B, Rachakonda S, et al. TERT promoter mutations in melanoma survival. Int J Cancer 2016.
- Pellegrini C, Maturo MG, Martorelli C, et al. Characterization of melanoma susceptibility genes in high-risk patients from Central Italy. Melanoma Res 2017.
- Espinosa P, Pfeiffer RM, García-Casado Z, et al. Risk factors for keratinocyte skin cancer in patients diagnosed with melanoma, a large retrospective study. Eur J Cancer 2016.
- Pasquali E, García-Borrón JC, Fargnoli MC, et al. MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project. Int J Cancer 2015.
- Fargnoli MC, Sera F, Suppa M, et al. Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype. J Eur Acad Dermatol Venereol 2014.
- Pergoli L, Favero C, Pfeiffer RM, et al. Blood DNA methylation, nevi number, and the risk of melanoma. Melanoma Res 2014.
- Shi J, Yang XR, Ballew B, et al. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nat Genet 2014.
